Comparison of nebulized epinephrine to albuterol in bronchiolitis

Paul Walsh, John Caldwell, Kemedy K. McQuillan, Steven Friese, Dale Robbins, Stephen J. Rothenberg

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Objectives: To compare the effect of nebulized racemic epinephrine to nebulized racemic albuterol on successful discharge from the emergency department (ED). Methods: Children up to their 18th month of life presenting to two teaching hospital EDs with a clinical diagnosis of bronchiolitis who were ill enough to warrant treatment but did not need immediate intubation were eligible for this double-blind randomized controlled trial (RCT). Patients received either three doses of racemic albuterol or one dose of racemic epinephrine plus two saline nebulizers. Disposition was decided 2 hours after the first nebulizer. Successful discharge was defined as not requiring additional bronchodilators in the ED after study drug administration and not subsequently admitted within 72 hours. Adjusted relative risks (aRR) were estimated using the modified Poisson regression with successful discharge as the dependent variable and study drug and severity of illness as exposures. Secondary analysis was performed for patients aged less than 12 months and first presentation. Results: The authors analyzed 703 patients; 352 patients were given albuterol and 351 epinephrine. A total of 173 in the albuterol group and 160 in the epinephrine group were successfully discharged (crude RR = 1.08, 95% confidence interval [CI] = 0.92 to 1.26). When adjusted for severity of illness, patients who received albuterol were significantly more likely than patients receiving epinephrine to be successfully discharged (aRR = 1.18, 95% CI = 1.02 to 1.36). This was also true among those with first presentation and in those less than 12 months of age. Conclusions: In children up to the 18th month of life, ED treatment of bronchiolitis with nebulized racemic albuterol led to more successful discharges than nebulized epinephrine.

Original languageEnglish (US)
Pages (from-to)305-313
Number of pages9
JournalAcademic Emergency Medicine
Volume15
Issue number4
DOIs
StatePublished - Apr 2008
Externally publishedYes

Fingerprint

Bronchiolitis
Albuterol
Epinephrine
Racepinephrine
Hospital Emergency Service
Nebulizers and Vaporizers
Confidence Intervals
Emergency Treatment
Bronchodilator Agents
Intubation
Teaching Hospitals
Pharmaceutical Preparations
Randomized Controlled Trials

Keywords

  • Albuterol
  • Bronchiolitis
  • Epinephrine

ASJC Scopus subject areas

  • Emergency Medicine
  • Medicine(all)

Cite this

Walsh, P., Caldwell, J., McQuillan, K. K., Friese, S., Robbins, D., & Rothenberg, S. J. (2008). Comparison of nebulized epinephrine to albuterol in bronchiolitis. Academic Emergency Medicine, 15(4), 305-313. https://doi.org/10.1111/j.1553-2712.2008.00064.x

Comparison of nebulized epinephrine to albuterol in bronchiolitis. / Walsh, Paul; Caldwell, John; McQuillan, Kemedy K.; Friese, Steven; Robbins, Dale; Rothenberg, Stephen J.

In: Academic Emergency Medicine, Vol. 15, No. 4, 04.2008, p. 305-313.

Research output: Contribution to journalArticle

Walsh, P, Caldwell, J, McQuillan, KK, Friese, S, Robbins, D & Rothenberg, SJ 2008, 'Comparison of nebulized epinephrine to albuterol in bronchiolitis', Academic Emergency Medicine, vol. 15, no. 4, pp. 305-313. https://doi.org/10.1111/j.1553-2712.2008.00064.x
Walsh P, Caldwell J, McQuillan KK, Friese S, Robbins D, Rothenberg SJ. Comparison of nebulized epinephrine to albuterol in bronchiolitis. Academic Emergency Medicine. 2008 Apr;15(4):305-313. https://doi.org/10.1111/j.1553-2712.2008.00064.x
Walsh, Paul ; Caldwell, John ; McQuillan, Kemedy K. ; Friese, Steven ; Robbins, Dale ; Rothenberg, Stephen J. / Comparison of nebulized epinephrine to albuterol in bronchiolitis. In: Academic Emergency Medicine. 2008 ; Vol. 15, No. 4. pp. 305-313.
@article{94838c3af7fc43cfb4913baf02e23547,
title = "Comparison of nebulized epinephrine to albuterol in bronchiolitis",
abstract = "Objectives: To compare the effect of nebulized racemic epinephrine to nebulized racemic albuterol on successful discharge from the emergency department (ED). Methods: Children up to their 18th month of life presenting to two teaching hospital EDs with a clinical diagnosis of bronchiolitis who were ill enough to warrant treatment but did not need immediate intubation were eligible for this double-blind randomized controlled trial (RCT). Patients received either three doses of racemic albuterol or one dose of racemic epinephrine plus two saline nebulizers. Disposition was decided 2 hours after the first nebulizer. Successful discharge was defined as not requiring additional bronchodilators in the ED after study drug administration and not subsequently admitted within 72 hours. Adjusted relative risks (aRR) were estimated using the modified Poisson regression with successful discharge as the dependent variable and study drug and severity of illness as exposures. Secondary analysis was performed for patients aged less than 12 months and first presentation. Results: The authors analyzed 703 patients; 352 patients were given albuterol and 351 epinephrine. A total of 173 in the albuterol group and 160 in the epinephrine group were successfully discharged (crude RR = 1.08, 95{\%} confidence interval [CI] = 0.92 to 1.26). When adjusted for severity of illness, patients who received albuterol were significantly more likely than patients receiving epinephrine to be successfully discharged (aRR = 1.18, 95{\%} CI = 1.02 to 1.36). This was also true among those with first presentation and in those less than 12 months of age. Conclusions: In children up to the 18th month of life, ED treatment of bronchiolitis with nebulized racemic albuterol led to more successful discharges than nebulized epinephrine.",
keywords = "Albuterol, Bronchiolitis, Epinephrine",
author = "Paul Walsh and John Caldwell and McQuillan, {Kemedy K.} and Steven Friese and Dale Robbins and Rothenberg, {Stephen J.}",
year = "2008",
month = "4",
doi = "10.1111/j.1553-2712.2008.00064.x",
language = "English (US)",
volume = "15",
pages = "305--313",
journal = "Academic Emergency Medicine",
issn = "1069-6563",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Comparison of nebulized epinephrine to albuterol in bronchiolitis

AU - Walsh, Paul

AU - Caldwell, John

AU - McQuillan, Kemedy K.

AU - Friese, Steven

AU - Robbins, Dale

AU - Rothenberg, Stephen J.

PY - 2008/4

Y1 - 2008/4

N2 - Objectives: To compare the effect of nebulized racemic epinephrine to nebulized racemic albuterol on successful discharge from the emergency department (ED). Methods: Children up to their 18th month of life presenting to two teaching hospital EDs with a clinical diagnosis of bronchiolitis who were ill enough to warrant treatment but did not need immediate intubation were eligible for this double-blind randomized controlled trial (RCT). Patients received either three doses of racemic albuterol or one dose of racemic epinephrine plus two saline nebulizers. Disposition was decided 2 hours after the first nebulizer. Successful discharge was defined as not requiring additional bronchodilators in the ED after study drug administration and not subsequently admitted within 72 hours. Adjusted relative risks (aRR) were estimated using the modified Poisson regression with successful discharge as the dependent variable and study drug and severity of illness as exposures. Secondary analysis was performed for patients aged less than 12 months and first presentation. Results: The authors analyzed 703 patients; 352 patients were given albuterol and 351 epinephrine. A total of 173 in the albuterol group and 160 in the epinephrine group were successfully discharged (crude RR = 1.08, 95% confidence interval [CI] = 0.92 to 1.26). When adjusted for severity of illness, patients who received albuterol were significantly more likely than patients receiving epinephrine to be successfully discharged (aRR = 1.18, 95% CI = 1.02 to 1.36). This was also true among those with first presentation and in those less than 12 months of age. Conclusions: In children up to the 18th month of life, ED treatment of bronchiolitis with nebulized racemic albuterol led to more successful discharges than nebulized epinephrine.

AB - Objectives: To compare the effect of nebulized racemic epinephrine to nebulized racemic albuterol on successful discharge from the emergency department (ED). Methods: Children up to their 18th month of life presenting to two teaching hospital EDs with a clinical diagnosis of bronchiolitis who were ill enough to warrant treatment but did not need immediate intubation were eligible for this double-blind randomized controlled trial (RCT). Patients received either three doses of racemic albuterol or one dose of racemic epinephrine plus two saline nebulizers. Disposition was decided 2 hours after the first nebulizer. Successful discharge was defined as not requiring additional bronchodilators in the ED after study drug administration and not subsequently admitted within 72 hours. Adjusted relative risks (aRR) were estimated using the modified Poisson regression with successful discharge as the dependent variable and study drug and severity of illness as exposures. Secondary analysis was performed for patients aged less than 12 months and first presentation. Results: The authors analyzed 703 patients; 352 patients were given albuterol and 351 epinephrine. A total of 173 in the albuterol group and 160 in the epinephrine group were successfully discharged (crude RR = 1.08, 95% confidence interval [CI] = 0.92 to 1.26). When adjusted for severity of illness, patients who received albuterol were significantly more likely than patients receiving epinephrine to be successfully discharged (aRR = 1.18, 95% CI = 1.02 to 1.36). This was also true among those with first presentation and in those less than 12 months of age. Conclusions: In children up to the 18th month of life, ED treatment of bronchiolitis with nebulized racemic albuterol led to more successful discharges than nebulized epinephrine.

KW - Albuterol

KW - Bronchiolitis

KW - Epinephrine

UR - http://www.scopus.com/inward/record.url?scp=42949149731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42949149731&partnerID=8YFLogxK

U2 - 10.1111/j.1553-2712.2008.00064.x

DO - 10.1111/j.1553-2712.2008.00064.x

M3 - Article

VL - 15

SP - 305

EP - 313

JO - Academic Emergency Medicine

JF - Academic Emergency Medicine

SN - 1069-6563

IS - 4

ER -